Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Fair Value Assets Measured on Recurring Basis for Cash, Cash Equivalents and Marketable Securities

The following table summarizes fair value measurements by level for the assets measured at fair value on a recurring basis for cash, cash equivalents and marketable securities:


	As of March 31, 2023
			Gross				Cash
	Adjusted		unrealized				and cash		Marketable
	cost		gains		Fair value		equivalents		securities
Cash	$	23,864	$	—	$	23,864	$	23,864	$	—
Level 1:
Money market accounts		99,048		—		99,048		99,048		—

Level 2:
Corporate bonds		5,985		—		5,985		5,985		—
U.S. Treasury securities		25,253		95		25,348		14,920		10,428
Institutional Insured Liquidity Deposit Savings		20,320		—		20,320		20,320		—
Total	$	174,470	$	95	$	174,565	$	164,137	$	10,428


	As of December 31, 2022
			Gross				Cash
	Adjusted		unrealized				and cash
	cost		gains		Fair value		equivalents
Cash	$	27,970	$	—	$	27,970	$	27,970
Level 1:
Money market accounts		113,534		—		113,534		113,534

Level 2:
Corporate bonds		6,474		—		6,474		6,474
U.S. Treasury securities		18,913		26		18,939		18,939
Institutional Insured Liquidity Deposit Savings		20,097		—		20,097		20,097
Total	$	186,988	$	26	$	187,014	$	187,014

Summary of Components of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) were as follows:


	Foreign			Unrealized		Accumulated
	currency			gains		other
	translation			on marketable		comprehensive
	adjustments			securities		income (loss)
Balance as of December 31, 2022	$	(269	)	$	26	$	(243	)
Other comprehensive income		170			69		239
Balance as of March 31, 2023	$	(99	)	$	95	$	(4	)